0001193125-20-265101 Sample Contracts

●] Shares Codiak BioSciences, Inc. UNDERWRITING AGREEMENT
Underwriting Agreement • October 7th, 2020 • Codiak BioSciences, Inc. • Biological products, (no disgnostic substances) • New York
Sample 1Sample 2Sample 3See All (631)
AutoNDA by SimpleDocs
CODIAK BIOSCIENCES, INC. [FORM OF] OFFICER INDEMNIFICATION AGREEMENT
Officer Indemnification Agreement • October 7th, 2020 • Codiak BioSciences, Inc. • Biological products, (no disgnostic substances) • Delaware

This Indemnification Agreemenst (“Agreement”) is made as of [________] by and between Codiak BioSciences, Inc., a Delaware corporation (the “Company”), and [Officer] (“Indemnitee”).1

Sample 1Sample 2Sample 3See All (49)
CODIAK BIOSCIENCES, INC. [FORM OF] DIRECTOR INDEMNIFICATION AGREEMENT
Director Indemnification Agreement • October 7th, 2020 • Codiak BioSciences, Inc. • Biological products, (no disgnostic substances) • Delaware

This Indemnification Agreement (“Agreement”) is made as of [ ] by and between Codiak BioSciences, Inc., a Delaware corporation (the “Company”), and [Director] (“Indemnitee”).

Sample 1Sample 2Sample 3See All (35)
Re: Employment Agreement
Employment Agreement • October 7th, 2020 • Codiak BioSciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts

This letter agreement (the “Agreement”) is made as of September 23, 2020 between Codiak BioSciences, Inc., a Delaware corporation (“Codiak” or the “Company”), and Ajay Verma, M.D., Ph.D (the “Executive”) (together, the “parties”) and is effective as of, and conditioned on, the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the date of such closing, the “Effective Date”).

Sample 1Sample 2
Re: Employment Agreement
Letter Agreement • October 7th, 2020 • Codiak BioSciences, Inc. • Biological products, (no disgnostic substances) • Massachusetts

This letter agreement (the “Agreement”) is made as of September 23, 2020 between Codiak BioSciences, Inc., a Delaware corporation (“Codiak” or the “Company”), and Douglas Williams, Ph.D. (the “Executive”) (together, the “parties”) and is effective as of, and conditioned on, the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the date of such closing, the “Effective Date”).

Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.